These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery. Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535 [TBL] [Abstract][Full Text] [Related]
3. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study. Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Aspirin Monotherapy versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting. Hess NR; Sultan I; Wang Y; Thoma F; Kilic A Am J Cardiol; 2021 Jun; 148():44-52. PubMed ID: 33667447 [TBL] [Abstract][Full Text] [Related]
5. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights. van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820 [TBL] [Abstract][Full Text] [Related]
6. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery. Wang A; Wu A; Wojdyla D; Lopes RD; Newby LK; Newman MF; Smith PK; Alexander JH Am Heart J; 2018 May; 199():150-155. PubMed ID: 29754654 [TBL] [Abstract][Full Text] [Related]
7. Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial. Benedetto U; Altman DG; Gerry S; Gray A; Lees B; Flather M; Taggart DP; Eur J Cardiothorac Surg; 2017 Sep; 52(3):456-461. PubMed ID: 28387790 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting. Ebrahimi R; Gupta S; Carr BM; Bishawi M; Bakaeen FG; Almassi GH; Collins J; Grover FL; Quin JA; Wagner TH; Shroyer ALW; Hattler B Am J Cardiol; 2018 Mar; 121(6):709-714. PubMed ID: 29402422 [TBL] [Abstract][Full Text] [Related]
9. Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe? Charif F; Hamdan R; Youness G; El Zein A; Issa M; Jassar Y; Younes M; Saab M J Cardiothorac Surg; 2019 Nov; 14(1):202. PubMed ID: 31775803 [TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting. Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791 [TBL] [Abstract][Full Text] [Related]
11. Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy. Schlachtenberger G; Deppe AC; Gerfer S; Choi YH; Zeriouh M; Liakopoulos O; Wahlers TCW Thorac Cardiovasc Surg; 2020 Dec; 68(8):714-722. PubMed ID: 32593177 [TBL] [Abstract][Full Text] [Related]
12. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis. Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154 [TBL] [Abstract][Full Text] [Related]
13. A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting. Straus S; Haxhibeqiri-Karabdic I; Grabovica SG; Granov N Med Arch; 2018 Feb; 72(1):31-35. PubMed ID: 29416215 [TBL] [Abstract][Full Text] [Related]
14. Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Miceli A; Duggan SM; Aresu G; de Siena PM; Romeo F; Glauber M; Caputo M; Angelini GD Eur J Cardiothorac Surg; 2013 Apr; 43(4):722-8. PubMed ID: 22733842 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Postoperative Events in Patients on Antiplatelet Therapy Undergoing Off-Pump Coronary Artery Bypass Grafting Surgery. Cheng Y; Liu X; Zhao Y; Sun Y; Zhang D; Liu F; Ma Y; Zhou Y Angiology; 2020 Sep; 71(8):704-712. PubMed ID: 32295386 [TBL] [Abstract][Full Text] [Related]
16. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Brener SJ; Kirtane AJ; Rinaldi MJ; Stuckey TD; Witzenbichler B; Weisz G; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Brodie BR; Mehran R; McAndrew T; Stone GW Circ Cardiovasc Interv; 2018 Oct; 11(10):e006853. PubMed ID: 30354629 [TBL] [Abstract][Full Text] [Related]
17. Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery. Qu J; Zhang H; Rao C; Chen S; Zhao Y; Sun H; Song Y; Liu S; Wang L; Feng W; Wang S; Hu S; Zheng Z J Am Heart Assoc; 2021 Jun; 10(11):e020413. PubMed ID: 33998246 [TBL] [Abstract][Full Text] [Related]
18. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. Tomšič A; Schotborgh MA; Manshanden JS; Li WW; de Mol BA Eur J Cardiothorac Surg; 2016 Nov; 50(5):849-856. PubMed ID: 27174551 [TBL] [Abstract][Full Text] [Related]
19. Risk/Benefit Tradeoff of Prolonging Dual Antiplatelet Therapy More Than 12 Months in TWILIGHT-Like High-Risk Patients After Complex Percutaneous Coronary Intervention. Wang HY; Dou KF; Yin D; Xu B; Zhang D; Gao RL Am J Cardiol; 2020 Oct; 133():61-70. PubMed ID: 32811654 [TBL] [Abstract][Full Text] [Related]
20. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel). Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]